These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 9821712
1. Prolonged suppressed thyroid-stimulating hormone levels in hyperthyroidism in a neonate born to a mother with Graves' disease. Hojo M, Momotani N, Ikeda N, Ueda A, Uno K, Ishikita T, Ishiguro A, Shimbo T. Acta Paediatr Jpn; 1998 Oct; 40(5):483-5. PubMed ID: 9821712 [Abstract] [Full Text] [Related]
2. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease. Higuchi R, Kumagai T, Kobayashi M, Minami T, Koyama H, Ishii Y. Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778 [Abstract] [Full Text] [Related]
3. Follow-up of newborns of mothers with Graves' disease. Levy-Shraga Y, Tamir-Hostovsky L, Boyko V, Lerner-Geva L, Pinhas-Hamiel O. Thyroid; 2014 Jun; 24(6):1032-9. PubMed ID: 24472020 [Abstract] [Full Text] [Related]
4. [Severe neonatal hyperthyroidism which reveals a maternal Graves' disease]. Guérin B, Vautier V, Boin-Gay V, Estrade G, Choulot JJ, Doireau V. Ann Endocrinol (Paris); 2004 Apr; 65(2):125-30. PubMed ID: 15247872 [Abstract] [Full Text] [Related]
5. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease. Uenaka M, Tanimura K, Tairaku S, Morioka I, Ebina Y, Yamada H. Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178 [Abstract] [Full Text] [Related]
6. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Matsuura N, Harada S, Ohyama Y, Shibayama K, Fukushi M, Ishikawa N, Yuri K, Nakanishi M, Yokota Y, Kazahari K, Oguchi H. Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225 [Abstract] [Full Text] [Related]
7. Different outcomes of neonatal thyroid function after Graves' disease in pregnancy: patient reports and literature review. Kamishlian A, Matthews N, Gupta A, Filipov P, Maclaren N, Anhalt H, Ten S. J Pediatr Endocrinol Metab; 2005 Dec; 18(12):1357-63. PubMed ID: 16459461 [Abstract] [Full Text] [Related]
8. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease. Bjørgaas MR, Farstad H, Christiansen SC, Blaas HG. Horm Res Paediatr; 2013 Dec; 79(1):39-43. PubMed ID: 23154300 [Abstract] [Full Text] [Related]
9. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Nachum Z, Rakover Y, Weiner E, Shalev E. Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156 [Abstract] [Full Text] [Related]
10. Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations. Volpé R, Ehrlich R, Steiner G, Row VV. Am J Med; 1984 Sep; 77(3):572-8. PubMed ID: 6548082 [Abstract] [Full Text] [Related]
11. Hyperthyroidism in an infant of a mother with autoimmune hypothyroidism with positive TSH receptor antibodies. Joshi K, Zacharin M. J Pediatr Endocrinol Metab; 2018 Apr 25; 31(5):577-580. PubMed ID: 29494342 [Abstract] [Full Text] [Related]
12. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, Kumahara Y, Miyai K. J Clin Endocrinol Metab; 1982 Jul 25; 55(1):108-12. PubMed ID: 6896207 [Abstract] [Full Text] [Related]
13. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K. J Clin Endocrinol Metab; 1992 Sep 25; 75(3):738-44. PubMed ID: 1517362 [Abstract] [Full Text] [Related]
14. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report. Arai N, Inaba M, Ichijyo T, Kagami H, Mine Y. J Med Case Rep; 2017 Jan 06; 11(1):9. PubMed ID: 28061802 [Abstract] [Full Text] [Related]
15. Management of neonates born to women with Graves' disease: a cohort study. Besançon A, Beltrand J, Le Gac I, Luton D, Polak M. Eur J Endocrinol; 2014 Jun 06; 170(6):855-62. PubMed ID: 24670885 [Abstract] [Full Text] [Related]
16. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease. Suzuki N, Yoshihara A, Yoshimura Noh J, Kinoshita K, Ohnishi J, Saito M, Sugino K, Ito K. Endocr J; 2020 Oct 28; 67(10):1019-1022. PubMed ID: 32522908 [Abstract] [Full Text] [Related]
20. Neonates Born to Mothers with Graves' Disease: 15 Year Experience of a Pediatric Endocrinology Department. Luz IR, Martins JR, Jerónimo M, Caetano JS, Cardoso R, Dinis I, Mirante A. Acta Med Port; 2020 Jul 01; 33(7-8):483-490. PubMed ID: 32669187 [Abstract] [Full Text] [Related] Page: [Next] [New Search]